Covered recipient · General Payments record
JUSTIN M MARKOW
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$400.68
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $221.38 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $57.54 | 3 |
| Lilly USA, LLC | $45.67 | 2 |
| SOBI, INC | $31.98 | 1 |
| Acerta Pharma LLC | $29.86 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.36 | 1 |
| Genentech USA, Inc. | $19.38 | 1 |
| Daiichi Sankyo Inc. | $14.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $29.86 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104653141 | CMS |
| Daiichi Sankyo Inc. | $14.59 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089452464 | CMS |
| Genentech USA, Inc. | $19.38 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133043236 | CMS |
| Lilly USA, LLC | $29.07 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135090819 | CMS |
| Lilly USA, LLC | $16.60 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135090821 | CMS |
| Merck Sharp & Dohme LLC | $21.40 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141923548 | CMS |
| Merck Sharp & Dohme LLC | $16.78 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141647114 | CMS |
| Merck Sharp & Dohme LLC | $19.36 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141647112 | CMS |
| Novartis Pharmaceuticals Corporation | $22.36 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087152204 | CMS |
| SOBI, INC | $31.98 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141421903 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.